Trial intelligence / Profile preview

Comparison of remimazolam besylate and propofol for general anesthesia with tracheal intubation

ChiCTR2200058488Phase 4Completed

Sponsor
The First Affiliated Hospital of Zhengzhou University
Start
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Time from end of administration to complete awakening. Started Apr 2022; status: completed.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2200058488.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200058488.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call